XML 27 R44.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Segment Reporting (Details) (USD $) In Thousands, unless otherwise specified | 3 Months Ended |
--- | --- | ---
Mar. 31, 2015 | Mar. 31, 2014 | Dec. 31, 2014
Summary of segment information |  |  |
Total assets | $ 263,223 us-gaap_Assets |  | $ 258,029 us-gaap_Assets
Net revenues from external customers | 14,602 us-gaap_Revenues | 15,958 us-gaap_Revenues |
Depreciation and amortization expense | 650 us-gaap_DepreciationDepletionAndAmortization | 668 us-gaap_DepreciationDepletionAndAmortization |
Operating (loss) income | 3,349 us-gaap_OperatingIncomeLoss | 5,100 us-gaap_OperatingIncomeLoss |
Interest expense, net | 2,973 us-gaap_InterestExpense | 248 us-gaap_InterestExpense |
Income tax expense from continuing operations | 15 us-gaap_IncomeTaxExpenseBenefit | 53 us-gaap_IncomeTaxExpenseBenefit |
Ligand |  |  |
Summary of segment information |  |  |
Total assets | 193,081 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember |  | 184,215 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember
Net revenues from external customers | 9,006 us-gaap_Revenues / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember | 6,791 us-gaap_Revenues / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember |
Depreciation and amortization expense | 53 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember | 66 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember |
Operating (loss) income | 458 us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember | (71)us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember |
Interest expense, net | 2,973 us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember | 248 us-gaap_InterestExpense / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember |
Income tax expense from continuing operations | 14 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember | 51 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = lgnd_LigandMember |
CyDex |  |  |
Summary of segment information |  |  |
Total assets | 70,142 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember |  | 73,814 us-gaap_Assets / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember
Net revenues from external customers | 5,596 us-gaap_Revenues / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember | 9,167 us-gaap_Revenues / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember |
Depreciation and amortization expense | 597 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember | 602 us-gaap_DepreciationDepletionAndAmortization / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember |
Operating (loss) income | 2,891 us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember | 5,171 us-gaap_OperatingIncomeLoss / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember |
Income tax expense from continuing operations | $ 1 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember | $ 2 us-gaap_IncomeTaxExpenseBenefit / us-gaap_StatementBusinessSegmentsAxis = lgnd_CydexPharmaceuticalsIncMember |

X
- Definition Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 + Details
Name: | us-gaap_Assets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 + Details
Name: | us-gaap_DepreciationDepletionAndAmortization
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 + Details
Name: | us-gaap_IncomeTaxExpenseBenefit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of the cost of borrowed funds accounted for as interest expense. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.9) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 9 -Article 9 + Details
Name: | us-gaap_InterestExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The net result for the period of deducting operating expenses from operating revenues. + References No definition available. + Details
Name: | us-gaap_OperatingIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_ReconciliationFromSegmentTotalsToConsolidatedAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=lgnd_CydexPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=lgnd_LigandMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |